Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Sep 4;17(3):1559325819872583. doi: 10.1177/1559325819872583

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 7. — Cytotoxicity of DTX solution, Tmab, PPLNs, pTmab-PPLNs, and eTmab-PPLNs. BT474 (A) and MCF7 (B) cells were treated with DTX solution, Tmab, PPLNs, pTmab-PPLNs, and eTmab-PPLNs at DTX concentrations of 0.1, 0.5, 2, 20, 200 and 2000 ng/mL for 48 hours, n = 6. DTX indicates docetaxel; eTmab-PPLNs, electrostatically conjugated trastuzumab-bearing poly (d, l-lactide-co-glycolide)/polyethylenimine/lipid nanoparticles; PPLNs, poly (d, l-lactide-co-glycolide)/polyethylenimine/lipid nanoparticles; Tmab, trastuzumab.